Tumor receptor imaging

David A. Mankoff, Jeanne Link, Hannah M. Linden, Lavanya Sundararajan, Kenneth Krohn

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Tumor receptors play an important role in carcinogenesis and tumor growth and have been some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in breast cancer. Knowledge of receptor expression is key for therapy directed at tumor receptors and traditionally has been obtained by assay of biopsy material. Tumor receptor imaging offers complementary information that includes evaluation of the entire tumor burden and characterization of the heterogeneity of tumor receptor expression. The nature of the ligand-receptor interaction poses a challenge for imaging - notably, the requirement for a low molecular concentration of the imaging probe to avoid saturating the receptor and increasing the background because of nonspecific uptake. For this reason, much of the work to date in tumor receptor imaging has been done with radionuclide probes. In this overview of tumor receptor imaging, aspects of receptor biochemistry and biology that underlie tumor receptor imaging are reviewed, with the estrogen-estrogen receptor system in breast cancer as an illustrative example. Examples of progress in radionuclide receptor imaging for 3 receptor systems - steroid receptors, somatostatin receptors, and growth factor receptors - are highlighted, and recent investigations of receptor imaging with other molecular imaging modalities are reviewed.

Original languageEnglish (US)
JournalJournal of Nuclear Medicine
Volume49
Issue numberSUPPL.6
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Neoplasms
Molecular Imaging
Estrogen Receptors
Breast Neoplasms
Somatostatin Receptors
Growth Factor Receptors
Steroid Receptors
Tumor Burden
Radioisotopes
Radionuclide Imaging
Biochemistry
Estrogens
Carcinogenesis
Ligands
Biopsy
Therapeutics
Growth

Keywords

  • Imaging
  • Receptors
  • Tumors

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

Tumor receptor imaging. / Mankoff, David A.; Link, Jeanne; Linden, Hannah M.; Sundararajan, Lavanya; Krohn, Kenneth.

In: Journal of Nuclear Medicine, Vol. 49, No. SUPPL.6, 01.06.2008.

Research output: Contribution to journalArticle

Mankoff, DA, Link, J, Linden, HM, Sundararajan, L & Krohn, K 2008, 'Tumor receptor imaging', Journal of Nuclear Medicine, vol. 49, no. SUPPL.6. https://doi.org/10.2967/jnumed.107.045963
Mankoff, David A. ; Link, Jeanne ; Linden, Hannah M. ; Sundararajan, Lavanya ; Krohn, Kenneth. / Tumor receptor imaging. In: Journal of Nuclear Medicine. 2008 ; Vol. 49, No. SUPPL.6.
@article{f1c3a748ac4d4da6bd1c1db9a059bd34,
title = "Tumor receptor imaging",
abstract = "Tumor receptors play an important role in carcinogenesis and tumor growth and have been some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in breast cancer. Knowledge of receptor expression is key for therapy directed at tumor receptors and traditionally has been obtained by assay of biopsy material. Tumor receptor imaging offers complementary information that includes evaluation of the entire tumor burden and characterization of the heterogeneity of tumor receptor expression. The nature of the ligand-receptor interaction poses a challenge for imaging - notably, the requirement for a low molecular concentration of the imaging probe to avoid saturating the receptor and increasing the background because of nonspecific uptake. For this reason, much of the work to date in tumor receptor imaging has been done with radionuclide probes. In this overview of tumor receptor imaging, aspects of receptor biochemistry and biology that underlie tumor receptor imaging are reviewed, with the estrogen-estrogen receptor system in breast cancer as an illustrative example. Examples of progress in radionuclide receptor imaging for 3 receptor systems - steroid receptors, somatostatin receptors, and growth factor receptors - are highlighted, and recent investigations of receptor imaging with other molecular imaging modalities are reviewed.",
keywords = "Imaging, Receptors, Tumors",
author = "Mankoff, {David A.} and Jeanne Link and Linden, {Hannah M.} and Lavanya Sundararajan and Kenneth Krohn",
year = "2008",
month = "6",
day = "1",
doi = "10.2967/jnumed.107.045963",
language = "English (US)",
volume = "49",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "SUPPL.6",

}

TY - JOUR

T1 - Tumor receptor imaging

AU - Mankoff, David A.

AU - Link, Jeanne

AU - Linden, Hannah M.

AU - Sundararajan, Lavanya

AU - Krohn, Kenneth

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Tumor receptors play an important role in carcinogenesis and tumor growth and have been some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in breast cancer. Knowledge of receptor expression is key for therapy directed at tumor receptors and traditionally has been obtained by assay of biopsy material. Tumor receptor imaging offers complementary information that includes evaluation of the entire tumor burden and characterization of the heterogeneity of tumor receptor expression. The nature of the ligand-receptor interaction poses a challenge for imaging - notably, the requirement for a low molecular concentration of the imaging probe to avoid saturating the receptor and increasing the background because of nonspecific uptake. For this reason, much of the work to date in tumor receptor imaging has been done with radionuclide probes. In this overview of tumor receptor imaging, aspects of receptor biochemistry and biology that underlie tumor receptor imaging are reviewed, with the estrogen-estrogen receptor system in breast cancer as an illustrative example. Examples of progress in radionuclide receptor imaging for 3 receptor systems - steroid receptors, somatostatin receptors, and growth factor receptors - are highlighted, and recent investigations of receptor imaging with other molecular imaging modalities are reviewed.

AB - Tumor receptors play an important role in carcinogenesis and tumor growth and have been some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in breast cancer. Knowledge of receptor expression is key for therapy directed at tumor receptors and traditionally has been obtained by assay of biopsy material. Tumor receptor imaging offers complementary information that includes evaluation of the entire tumor burden and characterization of the heterogeneity of tumor receptor expression. The nature of the ligand-receptor interaction poses a challenge for imaging - notably, the requirement for a low molecular concentration of the imaging probe to avoid saturating the receptor and increasing the background because of nonspecific uptake. For this reason, much of the work to date in tumor receptor imaging has been done with radionuclide probes. In this overview of tumor receptor imaging, aspects of receptor biochemistry and biology that underlie tumor receptor imaging are reviewed, with the estrogen-estrogen receptor system in breast cancer as an illustrative example. Examples of progress in radionuclide receptor imaging for 3 receptor systems - steroid receptors, somatostatin receptors, and growth factor receptors - are highlighted, and recent investigations of receptor imaging with other molecular imaging modalities are reviewed.

KW - Imaging

KW - Receptors

KW - Tumors

UR - http://www.scopus.com/inward/record.url?scp=46749092981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749092981&partnerID=8YFLogxK

U2 - 10.2967/jnumed.107.045963

DO - 10.2967/jnumed.107.045963

M3 - Article

C2 - 18523071

AN - SCOPUS:46749092981

VL - 49

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - SUPPL.6

ER -